Brenzavvy (bexagliflozin): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing

If diabetes medications had personalities, Brenzavvy would be the quiet coworker who gets a lot done without making a dramatic speech about it. The drug’s generic name is bexagliflozin, and it belongs to the SGLT2 inhibitor family, a class of medicines that helps the kidneys send extra glucose out through urine. In plain English: it helps lower blood sugar by giving some excess glucose a one-way ticket out of the body.

Brenzavvy is an FDA-approved prescription tablet used along with diet and exercise to improve glycemic control in adults with type 2 diabetes. It was approved in the United States in 2023, and its labeled use is focused on blood sugar control, not weight loss, not cosmetic “wellness,” and definitely not as a free pass to start a dessert fan club. That distinction matters because many readers compare it to other SGLT2 inhibitors that may have broader labeled uses in heart failure or kidney disease. Brenzavvy’s official U.S. role is simpler and narrower: it is a type 2 diabetes medication for adults who need help lowering glucose.

This guide breaks down how Brenzavvy works, what it is used for, how to take it, what side effects to watch for, which interactions deserve attention, what the pill looks like, and what day-to-day experience on the medication may feel like. The goal is clarity, not chemistry class trauma.

What Is Brenzavvy Used For?

Brenzavvy is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. That means it is usually part of a bigger glucose-management plan rather than a solo superhero cape situation. Your clinician may prescribe it alone or alongside other diabetes treatments such as metformin, a sulfonylurea, insulin, or other oral agents.

Because bexagliflozin works through the kidneys, it lowers blood sugar in a way that does not depend entirely on pushing the pancreas to release more insulin. That can make it an appealing option for some adults with type 2 diabetes. In clinical trials, Brenzavvy reduced A1C compared with placebo as monotherapy and when added to metformin. In one 24-week monotherapy study, the average A1C reduction was greater with Brenzavvy than placebo, and in a 24-week study added to metformin, more patients reached an A1C under 7% with Brenzavvy than with placebo. The drug was also shown to be noninferior to glimepiride and sitagliptin in certain comparison trials.

There is also a practical bonus people often ask about: weight. Brenzavvy is not approved as a weight-loss drug, but SGLT2 inhibitors can lead to some weight reduction in some patients. In a subgroup of adults with overweight or obesity in a Brenzavvy trial, average body weight dropped more with the medication than with placebo over 24 weeks. Useful? Possibly. Official indication? No.

How Brenzavvy Works

Bexagliflozin is an SGLT2 inhibitor. SGLT2 stands for sodium-glucose cotransporter 2, a protein in the kidneys that normally helps reabsorb glucose back into the bloodstream. Brenzavvy blocks that transporter, so more glucose leaves the body in urine instead of hanging around in the blood acting like it pays rent there.

This kidney-based mechanism helps explain several of the drug’s most common side effects and safety warnings. If more sugar is leaving through urine, you may urinate more often, feel thirstier, and become more prone to genital yeast infections or urinary tract infections. The same mechanism that helps lower glucose can also nudge the body toward dehydration in certain people, especially older adults, patients with kidney problems, people on diuretics, or anyone already running low on fluids.

Brenzavvy Dosing: How to Take It

The recommended Brenzavvy dosage is 20 mg by mouth once daily in the morning, with or without food. The tablet should not be crushed or chewed. If you miss a dose, take it as soon as you remember, but do not double the next dose. This is a medication, not a loyalty punch card.

Before starting Brenzavvy

Your healthcare provider should assess kidney function before you start and periodically during treatment. They should also correct volume depletion first if you are dehydrated. Brenzavvy is not recommended if your eGFR is below 30 mL/min/1.73 m².

When Brenzavvy should be temporarily stopped

The prescribing information recommends withholding Brenzavvy for at least 3 days before major surgery or procedures associated with prolonged fasting, if possible. It can be restarted when the patient is clinically stable and eating again. This matters because fasting, illness, and surgery can increase the risk of ketoacidosis.

Pictures: What Does Brenzavvy Look Like?

If you searched for Brenzavvy pictures, here is the pill-identification version without the mystery-game soundtrack. According to the U.S. prescribing information, Brenzavvy 20 mg tablets are blue, caplet-shaped, biconvex, bevel-edged, film-coated, and debossed with “2” and an inverted “2” on one side.

That description is useful for basic identification, but it should never replace pharmacist verification. If a tablet looks different from what your pharmacy previously dispensed, do not guess. Ask your pharmacist before taking it. Pill mix-ups are not the kind of surprises anybody wants before breakfast.

Common Brenzavvy Side Effects

The most commonly discussed Brenzavvy side effects include:

• Vaginal yeast infections
• Urinary tract infections
• Changes in urination, including needing to urinate more often, in larger amounts, or at night

Those are the headline effects from the medication guide, and they make sense given how the drug works. In clinical studies and postmarketing safety guidance, genital mycotic infections received particular attention. Women may notice itching, unusual discharge, or odor. Men can develop irritation, balanitis, or other genital fungal infections. If symptoms show up, do not try to win a stoicism contest. Call your clinician.

Some people also notice increased thirst, mild dizziness, or a “why am I suddenly planning my day around bathrooms?” phase early on. That does not automatically mean the drug is unsafe, but it does mean hydration and symptom monitoring matter.

Serious Warnings You Should Not Ignore

This is the section where the label stops being polite and gets very specific. Brenzavvy carries several important warnings, many of which are class warnings seen with SGLT2 inhibitors in general.

1) Ketoacidosis

Brenzavvy is not recommended for people with type 1 diabetes because it increases the risk of diabetic ketoacidosis (DKA). But ketoacidosis can also happen in some people with type 2 diabetes. The tricky part is that blood sugar may not be as high as people expect. Symptoms can include nausea, vomiting, stomach pain, feeling very unwell, and shortness of breath. If those symptoms appear, the drug should be stopped and urgent medical care is needed.

Situations that may raise the risk include missed insulin doses, illness with fever, reduced food intake, a ketogenic diet, dehydration, surgery, and heavy alcohol use. If you are sick and barely eating, this is not the time to wing it with medication decisions.

2) Lower limb amputation warning

In one randomized trial involving adults with type 2 diabetes who had cardiovascular disease or were at higher cardiovascular risk, lower limb amputations occurred more often with Brenzavvy than with placebo. The risk was highest in people with a prior amputation, peripheral vascular disease, or neuropathy. This does not mean everyone taking Brenzavvy is headed for disaster, but it does mean foot care mattersa lot.

If you have foot ulcers, infections, poor circulation, numbness, or wounds that are not healing, get them checked promptly. Diabetes already makes the feet a high-maintenance neighborhood; this warning means you should be even less willing to ignore trouble.

3) Volume depletion and kidney concerns

Brenzavvy can cause intravascular volume contraction, which may show up as dizziness, low blood pressure, or changes in kidney function. Some SGLT2 users have experienced acute kidney injury, including cases serious enough to require hospitalization. The risk may be higher in older adults, people with kidney impairment, people with low blood pressure, and those taking diuretics.

Translation: if you are already on the dry side, Brenzavvy may push things too far. Staying hydrated and checking kidney function are not optional box-checking exercises here.

4) Serious urinary and genital infections

The medication can increase the risk of urosepsis, pyelonephritis, and a rare but dangerous infection called Fournier’s gangrene, which affects the tissue around the genitals and perineum. Symptoms such as fever, severe pain, redness, swelling, tenderness, or feeling acutely ill need urgent evaluation.

More common infections, like yeast infections and UTIs, are less dramatic but still worth treating early. Burning urination, pelvic discomfort, blood in the urine, fever, or back pain should not be brushed off.

5) Low blood sugar when used with other diabetes drugs

Brenzavvy by itself does not usually act like a hypoglycemia machine. But when combined with insulin or an insulin secretagogue such as a sulfonylurea, the risk of low blood sugar goes up. That may mean the dose of the other drug needs adjustment. Symptoms of hypoglycemia can include shakiness, sweating, confusion, hunger, fast heartbeat, and weakness.

6) Allergic reactions

Brenzavvy is contraindicated in patients with a known hypersensitivity to bexagliflozin or any ingredient in the tablet. Serious allergic reactions such as angioedema or anaphylaxis are reasons to stop the drug and get immediate care.

Brenzavvy Interactions

Drug interactions with Brenzavvy are not wildly theatrical, but several deserve attention.

Interactions that may matter most

• Insulin and sulfonylureas: May increase the risk of hypoglycemia when used together with Brenzavvy.
• UGT enzyme inducers: May lower Brenzavvy exposure and make it less effective at lowering blood sugar.
• Lithium: SGLT2 inhibitors may decrease serum lithium levels, so monitoring may need to be more frequent when Brenzavvy is started or stopped.
• Diuretics: Not a classic metabolism interaction, but they may increase the risk of dehydration and low blood pressure when combined with Brenzavvy.

The prescribing information also notes that there were no clinically meaningful pharmacokinetic changes seen when bexagliflozin was taken with metformin, glimepiride, sitagliptin, exenatide, probenecid, or verapamil, and it did not have a clinically relevant effect on digoxin. Even so, “no big interaction” is not the same as “mention nothing to your prescriber.” Always review your full medication list, including supplements.

Who Should Avoid Brenzavvy or Use Extra Caution?

Brenzavvy may not be the best fitor may require extra monitoringif any of the following apply:

• You have type 1 diabetes
• You have eGFR below 30 mL/min/1.73 m²
• You have a history of serious allergic reactions to the drug
• You are pregnant, especially in the second or third trimester
• You are breastfeeding
• You are prone to dehydration or take medications that can lower blood pressure or deplete fluid volume
• You have foot ulcers, neuropathy, peripheral vascular disease, or a prior amputation
• You have had pancreatitis, pancreatic surgery, or situations that may increase ketoacidosis risk

The safety and effectiveness of Brenzavvy have not been established in pediatric patients. In older adults, the drug can still be used, but volume depletion-related side effects may be more common. It is also not recommended in severe hepatic impairment because it has not been adequately studied there.

Practical Tips for Taking Brenzavvy Safely

Hydration matters

Because the drug increases urinary glucose excretion, some people urinate more often and lose more fluid. Drink enough fluids, especially in hot weather, during illness, or if you exercise heavily.

Do not ignore infections

At the first hint of a genital yeast infection or urinary tract infection, call your healthcare provider. Fast treatment is easier than heroic treatment.

Check your feet regularly

Given the lower limb amputation signal in one trial, routine foot checks are a smart habit. Look for sores, cuts, redness, swelling, or skin changes.

Know your sick-day plan

If you develop vomiting, diarrhea, fever, or cannot eat and drink normally, call your clinician for instructions. SGLT2 drugs and dehydration are not an adorable duo.

Do not rely on urine glucose tests

Brenzavvy increases glucose in the urine by design, so urine glucose tests are not useful for monitoring how well the medicine is working. Blood glucose and A1C remain the better yardsticks.

Patient Experience: What Starting Brenzavvy Often Feels Like

Let’s add the real-world layer people actually care about. Not everybody asks, “What is the molecular mechanism of SGLT2 inhibition?” Some people ask the better question: What is life on this stuff actually like?

For many adults, the first noticeable change is simple: more trips to the bathroom. Brenzavvy works by helping the kidneys flush out extra glucose, so increased urination is not weirdit is basically the job description. Some patients notice this most in the first days or weeks. That may mean waking up at night to urinate, becoming more conscious of hydration, or planning errands with a little more “where is the nearest restroom?” energy than before.

Another common experience is thirst. Not always dramatic, but noticeable. Some people describe it as a subtle reminder to drink more water; others feel dry faster than usual, especially if they already take a diuretic, live in a hot climate, or exercise regularly. This is one reason clinicians often check on dizziness, blood pressure, and kidney function after starting therapy.

A more frustrating but very real day-to-day issue is the possibility of genital yeast infections or urinary symptoms. Patients may first notice itching, burning, irritation, discharge, or a change in odor. Men may notice redness or irritation; women may recognize the classic yeast infection pattern quickly. A good rule is to report symptoms early rather than trying home remedies for too long. When these infections are treated promptly, the experience is usually much less disruptive.

Some people feel encouraged by their home glucose readings within weeks, especially if Brenzavvy is added to metformin or another regimen that was not getting them where they wanted to be. Others appreciate that it is a once-daily morning tablet with no injection routine attached. That convenience factor matters more than drug labels sometimes admit. A treatment plan that fits into real life often works better than a theoretically perfect plan that people dread.

There is also a mindset shift that often comes with SGLT2 therapy: patients become more aware of sick-day safety. If you are vomiting, fasting, severely cutting carbs, drinking heavily, or heading into surgery, Brenzavvy is not the kind of medication you want to treat casually. Learning when to pause and when to seek help becomes part of the experience. It is less glamorous than a before-and-after photo, but it is far more important.

Finally, many people find that the best Brenzavvy experience happens when it is used as part of a larger routine: consistent meals, hydration, foot care, glucose monitoring, follow-up lab work, and honest communication with the prescriber. In other words, the pill can help, but it still expects you to show up for the group project.

Final Thoughts

Brenzavvy (bexagliflozin) is a useful option for some adults with type 2 diabetes who need additional blood sugar control. Its once-daily dosing is straightforward, and its kidney-based mechanism can complement other therapies. But the same mechanism that helps lower glucose also explains the most important side effects and warnings: more urination, dehydration risk, genital and urinary infections, ketoacidosis concerns, and a lower limb amputation warning that makes foot care especially important.

The bottom line is simple: Brenzavvy is not a casual over-the-counter vitamin with a fancy name. It is a prescription diabetes medication that can be helpful when used thoughtfully, monitored appropriately, and matched to the right patient. If you and your clinician are considering it, focus on the big questions: kidney function, current diabetes medications, infection history, foot health, hydration status, and whether you have a clear sick-day plan. Those details are where safe, effective use really lives.